FeaturedPortfolio news NXI Therapeutics Expands Management Team and Board Ahead of Next Growth Stage NXI Therapeutics (formerly Nextimmune), the specialist biotech developing next generation immunosuppressive drugs for autoimmune diseases and organ transplantation, today announces that it has appointed Dr…Adrian Limani30.11.2022
FeaturedPortfolio news InCephalo AG Announces Appointment of Lauren E. Abrey, MD as Chief Medical Officer InCephalo AG announces that Lauren E. Abrey, MD will join the company as Chief Medical Officer (CMO). Dr. Abrey will lead the clinical and medical…Arianna30.06.2022